Transgene Biotek Limited (TRABI.BO)

INR 7.34

(-0.53%)

EBITDA Summary of Transgene Biotek Limited

Transgene Biotek Limited's latest annual EBITDA in 2023 was -4.33 Million INR , down -41.76% from previous year.
Transgene Biotek Limited's latest quarterly EBITDA in 2024 Q1 was -4.12 Million INR , up 210.6% from previous quarter.
Transgene Biotek Limited reported an annual EBITDA of -8.77 Million INR in 2022, down -75.0% from previous year.
Transgene Biotek Limited reported an annual EBITDA of -2.5 Million INR in 2021, up 2.77% from previous year.
Transgene Biotek Limited reported a quarterly EBITDA of N/A for 2023 FY, down -41.76% from previous quarter.
Transgene Biotek Limited reported a quarterly EBITDA of -772.08 Thousand INR for 2023 Q2, up 7.54% from previous quarter.

Annual EBITDA Chart of Transgene Biotek Limited (2023 - 2006)

Historical Annual EBITDA of Transgene Biotek Limited (2023 - 2006)

Year	EBITDA	EBITDA Growth
2023	-4.33 Million INR	-41.76%
2022	-8.77 Million INR	-75.0%
2021	-2.5 Million INR	2.77%
2020	-2.6 Million INR	62.65%
2019	-6.84 Million INR	-66.44%
2018	13.54 Million INR	-110.6%
2017	52.68 Million INR	102596.59%
2016	-19.03 Million INR	99.61%
2015	-9.62 Million INR	39.49%
2014	-15.95 Million INR	-55.15%
2013	-1.16 Billion INR	-7.11%
2012	-9.59 Million INR	-105.29%
2011	181.21 Million INR	316.41%
2010	-83.73 Million INR	-523.89%
2009	16.4 Million INR	-0.99%
2008	16.47 Million INR	-5.3%
2007	17.87 Million INR	7.7%
2006	19.56 Million INR	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	-4.12 Million INR	210.6%
2023 FY	- INR	-41.76%
2023 Q2	-772.08 Thousand INR	7.54%
2023 Q1	-835.03 Thousand INR	-136.89%
2023 Q4	-2.68 Million INR	-149.3%
2023 Q3	-1.07 Million INR	-39.23%
2022 FY	- INR	-75.0%
2022 Q2	-4.86 Million INR	-361.16%
2022 Q3	-694.07 Thousand INR	85.73%
2022 Q1	-1.05 Million INR	-497.17%
2022 Q4	2.26 Million INR	426.1%
2021 Q4	265.57 Thousand INR	122.93%
2021 Q1	-840.21 Thousand INR	-34.01%
2021 FY	- INR	2.77%
2021 Q3	-1.15 Million INR	-52.19%
2021 Q2	-761.13 Thousand INR	9.41%
2020 FY	- INR	62.65%
2020 Q1	-960.86 Thousand INR	59.52%
2020 Q2	-1.32 Million INR	-38.07%
2020 Q3	312.99 Thousand INR	123.59%
2020 Q4	-626.97 Thousand INR	-300.31%
2019 FY	- INR	-66.44%
2019 Q4	-2.37 Million INR	-112.06%
2019 Q3	-1.11 Million INR	38.92%
2019 Q2	-1.83 Million INR	-20.56%
2019 Q1	-1.52 Million INR	2.98%
2018 Q4	-1.56 Million INR	4.41%
2018 FY	- INR	-110.6%
2018 Q3	-1.63 Million INR	-118.5%
2018 Q2	-750.07 Thousand INR	-377.6%
2018 Q1	-157.05 Thousand INR	0.0%
2017 FY	- INR	102596.59%
2016 FY	- INR	99.61%
2016 Q4	- INR	0.0%
2015 FY	- INR	39.49%
2015 Q4	- INR	0.0%
2014 FY	- INR	-55.15%
2013 FY	- INR	-7.11%
2012 Q3	-2.72 Million INR	-500.66%
2012 Q2	-454 Thousand INR	89.08%
2012 Q1	-4.15 Million INR	0.0%
2012 FY	- INR	-105.29%
2012 Q4	-140 Million INR	-5034.04%
2011 FY	- INR	316.41%
2010 FY	- INR	-523.89%
2009 FY	- INR	-0.99%
2008 FY	- INR	-5.3%
2007 FY	- INR	7.7%
2006 FY	- INR	0.0%

Peer EBITDA Comparison of Transgene Biotek Limited

Name	EBITDA	EBITDA Difference
Alfavision Overseas (India) Limited	10.12 Million INR	142.859%
Biocon Limited	41.52 Billion INR	100.01%
Blue Jet Healthcare Limited	2.29 Billion INR	100.189%
Concord Biotech Limited	4.65 Billion INR	100.093%
Dishman Carbogen Amcis Limited	3.07 Billion INR	100.141%
FERMENTA BIOTECH LIMITED	262.68 Million INR	101.652%
GENOMIC VALLEY BIOTECH LIMITED	147.4 Thousand INR	3043.651%
Lyka Labs Limited	167.58 Million INR	102.589%
Panacea Biotec Limited	-200.6 Million INR	97.837%
SAMSRITA LABS LIMITED	-2.46 Million INR	-76.35%
Servoteach Industries Limited	- INR	Infinity%
SMS Lifesciences India Limited	349.41 Million INR	101.242%
Supriya Lifescience Limited	1.83 Billion INR	100.236%
Syngene International Limited	10.84 Billion INR	100.04%
TAKE Solutions Limited	-1.05 Billion INR	99.587%
Titan Biotech Limited	360.29 Million INR	101.204%
Vanta Bioscience Limited	14.19 Million INR	130.576%